Mal-amido-PEG8-val-gly-PAB-OH is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Structure of 2353409-52-4
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Mal-amido-PEG8-val-gly-PAB-OH is a bifunctional linker used primarily in the field of bioconjugation. Here are some key applications of Mal-amido-PEG8-val-gly-PAB-OH:
Antibody-Drug Conjugates (ADCs): This compound is widely used in the synthesis of antibody-drug conjugates, which are designed for targeted cancer therapy. Mal-amido-PEG8-val-gly-PAB-OH serves as a linker to attach cytotoxic drugs to antibodies, facilitating the delivery of the drug specifically to cancer cells. This targeted approach minimizes off-target effects and enhances the therapeutic index.
Protein Labeling: Mal-amido-PEG8-val-gly-PAB-OH can be used for the covalent modification of proteins, allowing researchers to attach various probes for detection or purification purposes. Its PEG spacer provides enhanced solubility and reduced steric hindrance, ensuring efficient conjugation. This is particularly useful in proteomics and diagnostics for tracking and analyzing proteins.
Pharmacokinetics Studies: The PEG component of Mal-amido-PEG8-val-gly-PAB-OH can help improve the pharmacokinetic properties of small molecules and peptides. By enhancing the solubility and stability of the conjugates, it can prolong the circulation time of therapeutic compounds. Researchers use this advantage to develop drug formulations with better bioavailability and reduced immunogenicity.
Nanoparticle Functionalization: This compound is also employed in the functionalization of nanoparticles designed for drug delivery systems. Mal-amido-PEG8-val-gly-PAB-OH can be used to attach targeting ligands or therapeutic agents to the surface of nanoparticles. This application enhances the specificity and efficiency of nanoparticle-based treatments, especially in oncology and precision medicine.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00584 | Mal-amido-PEG8-acid | 1334177-86-4 | |
BADC-01740 | Mal-amido-PEG9-Val-Ala-PAB-SG3200 | 1817788-75-2 | |
BADC-01052 | Mal-amido-(CH2COOH)2 | 207613-14-7 | |
BADC-01066 | Mal-amido-PEG2-Val-Cit-PAB-PNP | 2112738-13-1 | |
BADC-01578 | Mal-amido-PEG2-acid | 756525-98-1 | |
BADC-00447 | Mal-amido-PEG2-NHS | 955094-26-5 | |
BADC-01267 | Mal-amido-PEG2-Val-Cit-PAB-OH |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.